Both in Pharmaceuticals
Nkarta vs Spruce Biosciences
Over the past year NKTX returned −26.1% and SPRB returned −59.1%; their daily moves had a correlation of 0.22.
NKTX −26.1% SPRB −59.1%Growth of $1, one year, split-adjusted
| Metric | NKTX | SPRB |
|---|---|---|
| Price | $1.53 | $42.81 |
| Market cap | $109.6M | $123.0M |
| Today | +0.66% | −3.91% |
| 1 month | −39.5% | −5.7% |
| 6 months | −50.3% | −27.9% |
| Year to date | −17.3% | −50.9% |
| 1 year | −27.5% | −61.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $182.8M | $89.2M |
| Dividend yield | — | — |
| Volatility (60d) | 61.1% | 64.5% |
| Short % of float | 8.1% | 22.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).